A physiologically based pharmacokinetic model to characterise the association between CYP2B6 polymorphisms and efavirenz pharmacokinetics in pregnancy
| dc.contributor.author | Julsing, Andrea Alison | |
| dc.date.accessioned | 2017-10-23T12:32:43Z | |
| dc.date.available | 2017-10-23T12:32:43Z | |
| dc.date.issued | 2017 | |
| dc.description | A research report submitted to the faculty of health science, University of the Witwatersrand, Johannesburg, in partial fulfillment of the requirements for the degree of MSC MED pharmaceutical affairs | en_ZA |
| dc.description.librarian | MT2017 | en_ZA |
| dc.identifier.uri | http://hdl.handle.net/10539/23315 | |
| dc.language.iso | en | en_ZA |
| dc.subject.mesh | Pregnancy | |
| dc.subject.mesh | Polymorphisms | |
| dc.subject.mesh | Efavirenz | |
| dc.title | A physiologically based pharmacokinetic model to characterise the association between CYP2B6 polymorphisms and efavirenz pharmacokinetics in pregnancy | en_ZA |
| dc.type | Thesis | en_ZA |